STOCK TITAN

MYOMO (MYO) SEC Filings, Jun 1-12, 2026

MYO NYSE

Myomo Inc. filings document material events for a Delaware medical-device company focused on wearable robotics and the MyoPro powered upper-limb orthosis. Recent Form 8-K disclosures furnish quarterly and annual operating results, revenue sources, MyoPro orders and authorizations, patient-pipeline activity, and exhibits tied to financial press releases.

The filing record also covers governance and capital-structure matters, including board appointments, director compensation arrangements, indemnification agreements, and loan and security agreements. These disclosures describe formal reporting of operating performance, financing terms, corporate governance actions and related risk and control subjects for MYO.

Rhea-AI Summary

MYOMO, INC. (MYO) identifies a proposed sale by its officer Harry Kovelman of 10,442 common shares on June 12, 2026, with an aggregate market value of $12,530.40.

The sale is solely to pay income taxes on restricted stock units that vested on June 11, 2026, when 20,979 shares were acquired. Kovelman made the stated irrevocable election on May 28, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.39%
Tags
other
-
Rhea-AI Summary

Myomo, Inc. officer Micah Mitchell reported a proposed sale of 9,061 common shares on June 12, 2026. The shares were to be sold solely to pay income taxes on the vesting of 19,813 restricted stock units on June 11, under an irrevocable election made May 28, 2026. The notice lists 38,638,669 common shares outstanding. Mitchell also reported sales of 6,529 shares for $8,653.27 on June 8 and 90,231 shares for $77,688.89 on May 14.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.39%
Tags
other
-
Rhea-AI Summary

MYOMO, INC. Chief Commercial Officer Micah Mitchell reported a compensation-related share disposition. On the vesting of restricted stock units, 6,529 shares of common stock were delivered on June 8, 2026 solely to cover income taxes at $1.33 per share. After this tax-withholding event, Mitchell directly holds 102,949 MYO shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.56%
Tags
insider
Rhea-AI Summary

MYOMO, INC. Chief Medical Officer Harry Kovelman reported a routine tax-related share disposition. On June 8, 2026, 7,635 shares of common stock were sold at $1.33 per share solely to cover income taxes from restricted stock units that vested on June 5, 2026. After this transaction, he directly holds 100,983 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.56%
Tags
insider
-
Rhea-AI Summary

MYOMO, INC. Chief Financial Officer David A. Henry had 10,050 shares of common stock withheld on June 8, 2026 to cover income taxes from restricted stock units that vested on June 5, 2026. After this tax-withholding disposition, he directly holds 435,124 shares of MYO common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.56%
Tags
insider
-
Rhea-AI Summary

MYOMO, INC. director F. Kirk Thomas reported an open-market purchase of 40,002 shares of common stock on June 5, 2026 at a weighted average price of $1.27 per share. The filing notes the shares were bought in multiple lots at prices ranging from $1.23 to $1.30 per share. Following this transaction, Thomas directly owns 693,865 shares of Myomo common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.56%
Tags
insider
Rhea-AI Summary

MYOMO, INC. Chief Commercial Officer Micah Mitchell sold 90,231 shares of common stock in open-market transactions on May 14, 2026. The weighted average sale price was $0.861 per share, with individual lots ranging from $0.85 to $0.889 per share. After these sales, Mitchell directly holds 109,478 shares of MYOMO common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.34%
Tags
insider
-
Rhea-AI Summary

MYOMO, Inc. identifies Officer Harry Kovelman as planning to sell 7,635 common shares on June 8, 2026, with an aggregate market value of $10,154.55. The sale is solely to pay income taxes on the vesting of 17,666 restricted stock units on June 5, 2026, pursuant to an irrevocable election made May 28, 2026. The reported number of shares outstanding is 38,638,669.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.34%
Tags
other
-
Rhea-AI Summary

MYOMO, Inc. officer Micah Mitchell reported a proposed sale of 6,529 common shares, with an approximate sale date of June 8, 2026, and an aggregate market value of $8,683.57. He stated the shares would be sold solely to pay income taxes on the vesting of 16,666 restricted stock units on June 5, 2026, following an irrevocable election made May 28, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.34%
Tags
other
Rhea-AI Summary

MYOMO, INC. director F. Kirk reported an open-market purchase of 25,000 shares of Common Stock on May 28, 2026 at $0.993 per share. The shares were bought in multiple lots at this price. Following the transaction, his direct holdings increased to 653,863 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.42%
Tags
insider

FAQ

How many MYOMO (MYO) SEC filings are available on StockTitan?

StockTitan tracks 100 SEC filings for MYOMO (MYO), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for MYOMO (MYO)?

The most recent SEC filing for MYOMO (MYO) was filed on November 12, 2026.